SK13642001A3 - Farmaceutický prípravok na orálne podávanie obsahujúci tolperizón - Google Patents

Farmaceutický prípravok na orálne podávanie obsahujúci tolperizón Download PDF

Info

Publication number
SK13642001A3
SK13642001A3 SK1364-2001A SK13642001A SK13642001A3 SK 13642001 A3 SK13642001 A3 SK 13642001A3 SK 13642001 A SK13642001 A SK 13642001A SK 13642001 A3 SK13642001 A3 SK 13642001A3
Authority
SK
Slovakia
Prior art keywords
tolperisone
isomer
oral administration
composition according
racemate
Prior art date
Application number
SK1364-2001A
Other languages
English (en)
Slovak (sk)
Inventor
Werner Frantsits
Original Assignee
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika Ag filed Critical Sanochemia Pharmazeutika Ag
Publication of SK13642001A3 publication Critical patent/SK13642001A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SK1364-2001A 1999-04-01 1999-11-16 Farmaceutický prípravok na orálne podávanie obsahujúci tolperizón SK13642001A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0059499A AT409083B (de) 1999-04-01 1999-04-01 Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
PCT/AT1999/000276 WO2000059508A1 (fr) 1999-04-01 1999-11-16 Preparation pharmaceutique de tolperisone pour administration orale

Publications (1)

Publication Number Publication Date
SK13642001A3 true SK13642001A3 (sk) 2002-03-05

Family

ID=3494723

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1364-2001A SK13642001A3 (sk) 1999-04-01 1999-11-16 Farmaceutický prípravok na orálne podávanie obsahujúci tolperizón

Country Status (23)

Country Link
US (1) US6500455B1 (fr)
EP (1) EP1165081B1 (fr)
JP (1) JP2002541107A (fr)
AT (1) AT409083B (fr)
AU (1) AU1136400A (fr)
CA (1) CA2366841C (fr)
CZ (1) CZ20013404A3 (fr)
DE (1) DE59912101D1 (fr)
EE (1) EE04833B1 (fr)
ES (1) ES2168241T3 (fr)
HR (1) HRPK20010706B1 (fr)
HU (1) HUP0200669A3 (fr)
IL (2) IL145559A0 (fr)
NO (1) NO20014738L (fr)
NZ (1) NZ514129A (fr)
PL (1) PL197545B1 (fr)
PT (1) PT1165081E (fr)
RU (1) RU2223098C2 (fr)
SK (1) SK13642001A3 (fr)
TR (1) TR200102811T2 (fr)
UA (1) UA71613C2 (fr)
WO (1) WO2000059508A1 (fr)
YU (1) YU67501A (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300929A3 (en) * 2003-04-09 2005-06-28 Richter Gedeon Vegyeszet Analgetic and/or muscle relaxant pharmaceutical composition
DE10341923A1 (de) * 2003-09-11 2005-04-07 Heinl, Alexander, Dr.med. Verwendung von Tolperison
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE10359335A1 (de) * 2003-10-23 2005-05-25 Viatris Gmbh & Co. Kg Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
AT500144A1 (de) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
MX2008013437A (es) * 2006-04-20 2009-03-06 Sanochemia Pharmazeutika Ag Metodo para administrar tolperisona.
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
SG174095A1 (en) * 2006-08-23 2011-09-29 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8722929B2 (en) 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
AU2007325629A1 (en) * 2006-11-28 2008-06-05 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
AT505225A1 (de) 2007-04-26 2008-11-15 Sanochemia Pharmazeutika Ag 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
HUP0700485A3 (en) * 2007-07-23 2010-01-28 Richter Gedeon Nyrt Pharmaceutical composition with controlled release containing tolperisone
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
US8865732B2 (en) 2008-03-21 2014-10-21 Novartis Ag Heterocyclic compounds and uses thereof
US20100249423A1 (en) * 2009-03-09 2010-09-30 Sanochemia Pharmazeutika Ag Tolperisone controlled release tablet
CN102438597A (zh) 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154918A (en) * 1974-10-08 1976-05-14 Nippon Kayaku Kk Jozaino seizoho
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5340779A (en) * 1976-09-21 1978-04-13 Nippon Kayaku Co Ltd Optically active tolpertisone, their preparation and pharmaceuticals containting the same
JPS58135806A (ja) * 1982-02-08 1983-08-12 Nippon Kayaku Co Ltd 多層コ−チング製剤
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPH0637389B2 (ja) * 1986-12-26 1994-05-18 北陸製薬株式会社 頻尿治療剤
JPH0720866B2 (ja) 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
IL87710A (en) * 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
MY115126A (en) * 1990-04-27 2003-04-30 Seikisui Chemical Co Ltd Percutaneously absorbable eperisone or tolperisone preparation.
US5128145A (en) * 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
TW209174B (fr) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
DE69220317T2 (de) * 1991-10-01 1997-10-16 Takeda Chemical Industries Ltd Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance

Also Published As

Publication number Publication date
NO20014738L (no) 2001-10-23
AT409083B (de) 2002-05-27
CA2366841A1 (fr) 2000-10-12
RU2223098C2 (ru) 2004-02-10
US6500455B1 (en) 2002-12-31
DE59912101D1 (de) 2005-06-30
HRPK20010706B1 (en) 2004-12-31
PL197545B1 (pl) 2008-04-30
NO20014738D0 (no) 2001-09-28
NZ514129A (en) 2003-04-29
EE200100503A (et) 2003-02-17
EP1165081B1 (fr) 2005-05-25
YU67501A (sh) 2004-07-15
ES2168241T3 (es) 2005-11-01
EE04833B1 (et) 2007-06-15
CA2366841C (fr) 2008-10-07
UA71613C2 (uk) 2004-12-15
PT1165081E (pt) 2005-08-31
ES2168241T1 (es) 2002-06-16
IL145559A (en) 2008-12-29
JP2002541107A (ja) 2002-12-03
CZ20013404A3 (cs) 2002-02-13
HRP20010706A2 (en) 2003-02-28
ATA59499A (de) 2001-10-15
EP1165081A1 (fr) 2002-01-02
WO2000059508A1 (fr) 2000-10-12
PL351377A1 (en) 2003-04-07
HUP0200669A3 (en) 2002-11-28
TR200102811T2 (tr) 2002-05-21
AU1136400A (en) 2000-10-23
IL145559A0 (en) 2002-06-30
HUP0200669A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
SK13642001A3 (sk) Farmaceutický prípravok na orálne podávanie obsahujúci tolperizón
FI82187B (fi) Foerfarande foer framstaellning av lagerstabila snabbsoenderfallande farmaceutiska aktivaemnespresstycken.
AU603624B2 (en) Galenical formulation
US4784858A (en) Controlled release tablet
AU760006B2 (en) Method for making granules with masked taste and instant release of the active particle
US5211958A (en) Pharmaceutical composition and process for its preparation
EA001537B1 (ru) Гранулят для получения быстрораспадающихся и быстрорастворяющихся композиций, содержащих большое количество лекарственного средства
BG64885B1 (bg) Фармацевтичен състав на топирамат
AU2010211980A1 (en) Dual release pharmaceutical suspension
EA014707B1 (ru) Новая форма введения рацекадотрила
SK8252001A3 (en) Controlled release formulation of divalproex sodium
WO2009074995A1 (fr) Compositions à croquer de citrate de sildénafil au goût masqué
JP3836893B2 (ja) ポリカルボフィルカルシウム含有製剤
CA1334933C (fr) Composition pharmaceutique et methode de preparation
KR20010114227A (ko) 직접 압착에 의한 정제의 제조에 적합한, 고 함량의ｌ-카르니틴 또는 알카노일 ｌ-카르니틴 함유 과립
US20090149543A1 (en) Solid pharmaceutical compositions comprising lumiracoxib
WO2009130715A1 (fr) Compositions orales de tramadol se désintégrant rapidement
HUE029193T2 (en) Delayed release drug formulations of thiocolchicoside